Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $19 Million - $22 Million
-141,956 Reduced 80.0%
35,483 $5.29 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $23.5 Million - $29.3 Million
177,439 New
177,439 $23.9 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $615,849 - $782,946
4,475 New
4,475 $685,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $6.5 Million - $8.23 Million
-60,519 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $434,856 - $493,627
4,087 Added 7.24%
60,519 $6.53 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $5.94 Million - $6.61 Million
56,432 New
56,432 $6.36 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $2.45 Million - $2.7 Million
-23,964 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $1.93 Million - $2.6 Million
23,964 New
23,964 $2.57 Million
Q3 2020

Nov 06, 2020

SELL
$85.91 - $100.83 $824,306 - $967,463
-9,595 Closed
0 $0
Q2 2020

Aug 07, 2020

SELL
$73.37 - $98.18 $3.69 Million - $4.94 Million
-50,353 Reduced 83.99%
9,595 $942,000
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $1.86 Million - $2.82 Million
28,787 Added 92.38%
59,948 $4.57 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $2.2 Million - $2.75 Million
-30,483 Reduced 49.45%
31,161 $2.76 Million
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $164,188 - $197,402
-2,607 Reduced 4.06%
61,644 $4.67 Million
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $4.22 Million - $5.4 Million
64,251 New
64,251 $4.67 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $1.98 Million - $2.45 Million
-25,496 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $2.64 Million - $2.93 Million
-29,659 Reduced 53.77%
25,496 $2.41 Million
Q2 2018

Aug 07, 2018

BUY
$89.78 - $106.23 $86,368 - $102,193
962 Added 1.78%
55,155 $5.11 Million
Q1 2018

May 03, 2018

BUY
$92.01 - $123.21 $4.99 Million - $6.68 Million
54,193 New
54,193 $5.13 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.